0000899243-23-008782.txt : 20230316 0000899243-23-008782.hdr.sgml : 20230316 20230316202422 ACCESSION NUMBER: 0000899243-23-008782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brand Florian CENTRAL INDEX KEY: 0001860682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 23740452 MAIL ADDRESS: STREET 1: C/O ATAI LIFE SCIENCES N.V. STREET 2: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-14 0 0001840904 ATAI Life Sciences N.V. ATAI 0001860682 Brand Florian WALLSTRASSE 16 BERLIN 2M 10179 GERMANY 0 1 0 0 See Remarks Stock Option 1.18 2023-03-14 4 A 0 1600000 0.00 A 2033-03-14 Common Shares 1600000 1600000 D Restricted Stock Unit 2023-03-14 4 A 0 700000 0.00 A Common Shares 700000 700000 D The stock option shall vest as to 25% of the underlying shares on March 14, 2024, and in 36 substantially equal monthly installments thereafter. Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units will vest on the first anniversary of the grant date and 50% will vest on the second anniversary of the grant date. Co-Founder and Chief Executive Officer /s/ Ryan Barrett, Attorney-in-fact 2023-03-16